Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

NCT04899908 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
Brain Metastases
Melanoma
Lung Cancer
Breast Cancer
HER2-positive Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
SRS
SRT
Whole Brain Radiation
Stereotactic Radiation
AGuIX
Nanoparticle
Cystic
Brain Tumor

Interventions

RADIATION: Stereotactic Radiation
DRUG: AGuIX gadolinium-based nanoparticles
OTHER: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]